Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Mustang Bio Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
KA
Kestra Advisory Services, LLC
|
197.0K | 2.93% | +20.9K (+11.9%) | Q3 '25 | 0.0% | |
|
Shares held by quarter
Peak holding197.0K (Q2'26)
Change over 8 quarters+197.0K
Share of the company2.930%
|
||||||
|
GC
Geode Capital Management, LLC
|
42.2K | 0.63% | −50.6K (−54.5%) | 2023 | 0.0% | |
|
Shares held by quarter
Peak holding284.4K (Q4'24)
Change over 8 quarters−203.2K
Share of the company0.630%
|
||||||
24 more super investors behind a free account
See every manager holding Mustang Bio Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FE
Fidelity Concord Street Trust
|
$18.2K | 33.9K | 0.50% | 0.00% | August 31, 2026 |
|
VE
Vanguard Index Funds
|
$18K | 25.7K | 0.38% | 0.00% | June 30, 2026 |
3 more funds behind a free account
See every fund holding Mustang Bio Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
FB
Fortress Biotech, Inc.
5%+ holder
13D · 8.0%
|
537.2K | 7.98% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
HN
Herskowitz Neil
Insider
|
2.3K | 0.03% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company0.030%
|
||||||
3 more holders behind a free account
See every insider and 5%+ holder of Mustang Bio Inc.
Sign up freeLoading...